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To estimate the basic reproduction number (R0) for COVID-19 in Western Europe.
Methods
Data (official statistics) on the cumulative incidence of COVID-19 at the start of the outbreak
(before any confinement rules were declared) were retrieved in the 15 largest countries in
Western Europe, allowing us to estimate the exponential growth rate of the disease. The
rate was then combined with estimates of the distribution of the generation interval as recon-
structed from the literature.
Results
Despite the possible unreliability of some official statistics about COVID-19, the spread of
the disease appears to be remarkably similar in most European countries, allowing us to
estimate an average R0 in Western Europe of 2.2 (95% CI: 1.9–2.6).
Conclusions
The value of R0 for COVID-19 in Western Europe appears to be significantly lower than that
in China. The proportion of immune persons in the European population required to stop the
outbreak could thus be closer to 50% than to 70%.
Introduction
The COVID-19 pandemic is an ongoing pandemic of coronavirus disease caused by acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). It was first identified in December 2019
in Wuhan, China. Spreading rapidly around the world [1], it was declared a public health
emergency of international concern in January 2020 and a pandemic in March 2020 when all
inhabited continents and more than 200 countries were affected. By early 2021, more than 90
million cases were confirmed worldwide and more than 2 million deaths were attributed to
COVID-19.
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The basic reproduction number (R0) is a well-known epidemiological concept to measure
the spread of an infectious disease [2–5]. It is defined as the average number of secondary
cases that one primary case will generate in a given population, where nobody is either
immune or vaccinated. It is thus defined at the start of an outbreak, in particular, before any
public health measure is undertaken. A value of R0 above 1 implies an exponential growth in
the number of cases of the disease in the population, while a value of R0 below 1 indicates that
the outbreak will stop. As a consequence, the epidemic will also stop once the proportion P of
immune (or vaccinated) persons in the population reaches value 1−1/R0, which guarantees an
“effective reproduction number” of R = R0(1−P) that is smaller than one. It is thus of interest
to estimate the value of R0 for an emerging disease, such as the current COVID-19 outbreak.
Most reported R0 for COVID-19 were estimated using Chinese data. A comprehensive
meta-analysis including 29 studies about China reported an estimated value of R0 = 3.32 (95%
CI: 2.81−3.82) [6], indicating that the proportion of immune persons needed to stop the out-
break would be close to 70%. However, as explained e.g. by Delamater et al. [7], the value of R0
is essentially the combination of three factors: the (average) number of daily contacts that one
contagious person has, the probability of transmission of the disease during such a contact,
and the (average) number of days that an infected person is contagious. While the latter factor
mainly depends on the biological characteristics of the disease, the first two factors strongly
depend on the social habits of a given population. Since these habits may vary considerably in
countries with different cultures, an estimated value of R0 in China is not necessarily valid in
Europe.
To date, published studies reporting an R0 for COVID-19 in Europe are rare. The recent
meta-analysis by Billah et al [8] included only three studies with European data, the first pro-
viding an estimate of R0 in France, Germany, Italy and Spain [9], the second in Spain, where
an effective reproduction number was also estimated after a lockdown was declared [10], the
third focusing on a single Italian region [11]. Another study by Hilton and Keeling [12] used a
sophisticated methodology to combine epidemiological data from China with country-specific
“synthetic contact matrices” measuring the density of human contact networks, to estimate an
R0 in 152 countries, including most European ones. A typical difficulty in studies estimating
an R0 is the possible unreliability of the epidemiological data used [13]. The goal of the present
study is to estimate a value of R0 for the COVID-19 outbreak in Western Europe that is as reli-
able as possible by combining data from several countries. We thus apply the principle of “bor-
rowing strength” [14], trying to consolidate the partly unreliable data collected in some
countries by pooling them with better data collected in other (albeit similar) countries. To do
this, we robustly estimate the exponential growth rate of the disease in 15 Western European
countries based on the number of reported daily incidences (new cases) and then average
them to obtain an overall estimate of the exponential growth rate for Western Europe. To
obtain an estimated value of R0, the latter estimation is combined with an estimation of the
parameters of the generation interval distribution, i.e., the time needed for an infected person
(primary case) to infect another person (secondary case), as reconstructed from the literature.
Data
We downloaded incidence data for COVID-19 from the EU Open Data Portal on September
30, 2020 (https://data.europa.eu/euodp/en/data/dataset/covid-19-coronavirus-data). We used
the daily numbers of new COVID-19 cases from the start of the outbreak until (and including)
March 15, 2020, as reported in all the 15 countries in Western Europe with at least one million
inhabitants (https://fr.m.wikipedia.org/wiki/Europe_de_l%27Ouest): Austria (AT), Belgium
(BE), Switzerland (CH), Germany (DE), Denmark (DK), Spain (ES), Finland (FI), France
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(FR), Ireland (IE), Italy (IT), the Netherlands (NL), Norway (NO), Portugal (PT), Sweden (SE)
and the United Kingdom (UK). Note that it was important to consider a period at the very
beginning of the COVID outbreak, at a time when social habits were not affected by the pan-
demic and its consequences. We included data until March 15 to ensure that all selected coun-
tries had data for at least 7 days (see below). From there, we calculated the cumulative
incidence of COVID-19 for a given day in a given country by summing all the new cases
observed up to and including that day in that country. The obtained daily cumulative inci-
dence numbers are plotted on Fig 1 for the 15 countries on a (natural) logarithmic scale, where
they are supposed to be aligned at the start of an outbreak that is growing exponentially, which
was largely the case here, validating the choice of our selected period.
Since incidences based on too few cases are unreliable, the standard error (and thus statisti-
cal imprecision) of the logarithm of an incidence being inversely proportional to the square
root of the number of cases [15, p. 238], only daily cumulative incidence values greater than or
equal to 20 were retained in our analysis, as done in Musa et al [16] to estimate an exponential
growth rate in Africa. The first country to reach this milestone was Italy on February 23, 2020,
which is referred to as day 1 in the graphics. March 15, 2020 is thus day 22. The last countries
to reach this milestone were Finland and Ireland (on day 16, i.e., on March 9, 2020). Of note,
no data were available on March 10 in Ireland and on March 11 in Finland (we thus assumed
that no new cases were reported). We also excluded from our analysis those data collected dur-
ing a time period after a national confinement had been declared. Before March 15, this was
Fig 1. Cumulative incidence of COVID-19 over a selected period in 15 countries in Western Europe (log scale). For each country, a line has been added to the plot,
whose intercept represents the center of gravity of the data, and whose slope represents the estimated exponential growth rate of the disease at the start of the outbreak.
The selected period was different for each country, ranging from February 23 (day 1) to March 15 (day 22).
https://doi.org/10.1371/journal.pone.0248731.g001
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the case in Austria (March 13), Denmark (March 13), Norway (March 12) and Italy (March
10). Thus, the number of days included in our analysis varied from country to country, rang-
ing from 7 days (for Finland and Ireland) to 17 days (for Spain, France, Italy and the UK) or
even 18 days (for Germany).
Methods
The exponential growth rate ρ of a disease in a population is defined as the daily increase in
the cumulative incidence, calculated on the natural logarithmic scale, at the start of an out-
break. Thus ρ = log(Nj+1)−log(Nj) = log(Nj+1/Nj), where Nj is the cumulative incidence
observed on day j in the examined population. Therefore, exp(ρ) = Nj+1/Nj represents the daily
increase (expressed as a percentage) of the cumulative incidence. For example, a value of ρ =
0.25 indicates that one can multiply the cumulative incidence observed on a given day by exp
(ρ) = 1.28 to obtain the cumulative incidence for the next day (where the daily increase is
28%). To get an estimate r̂ of ρ, one must thus average (or smooth) the ratios Nj+1/Nj over a
selected period. One possible method for estimating ρ is to consider the slope of a Poisson
regression of log(Nj) on day j (including all days j in the selected period), as done e.g. in Yuan
et al [9]. However, this method might not be robust to the unreliability of some data; for exam-
ple, a “weekend effect”, where a few cases not reported during a weekend might be reported on
the following Monday, might skew the data and negatively affect the model. This is why we
estimated ρ in each country as the (natural) logarithm of the median of the empirical ratios Nj
+1/Nj observed over the selected period. This method is robust to unreliability of some data
provided that half of the successive cumulative incidences reported in a given country are reli-
able. To obtain an overall estimate r̂ of ρ in Western Europe, the estimations of ρ obtained in
each country were averaged across all 15 countries. In a same spirit as in a meta-analysis, we
used a weighted average, where the weight assigned to a country was proportional to the num-
ber of days included in the analysis for that country.
Let now gðt; m; s2GÞ be the density function of the generation interval G, where a generation
interval is defined as the time needed for an infected person to infect another person with
COVID-19 (expressed in days), while μ and s2G indicate the mean and variance of G, respec-
tively. As explained in detail by Wallinga and Lipsitch [17], knowing the distribution of G







The distribution of G and its parameters are usually estimated empirically by considering
confirmed infector-infected pairs [1, 18–22]. However, since a diseased subject usually comes
under observation only from the onset of symptoms, one in general only disposes of the time
difference between the dates when the infector and infected show symptoms, referred to as the
serial interval S. This is why in most studies the distribution of S is taken as a proxy of the dis-
tribution of G in (1) [18, 22]. However, as acknowledged by Ganyani et al. [19], while the dis-
tributions of G and S should have the same mean μ, the variance s2S of S is in general larger
than s2G. In addition, while S may happen to be negative (when the infected person develops
symptoms before the infector) and may exhibit a symmetric (e.g. close to normal) distribution
[18], G is always positive by definition and is typically characterized by a distribution that is
skewed to the right, such as a Weibull or a gamma distribution.
The relationship between s2G and R0, which is not immediately evident from (1), can be
highlighted by considering a distribution with an explicit solution of the integral to the denom-
inator of (1), which is the moment generating function of the random variable G. A convenient
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One can easily verify that expression (2) is a decreasing function of s2G, converging to the
well-known approximation R0�exp(μρ) which is sometimes used in the literature to estimate
R0 [23]. Thus, underestimating the variability of G in (1) or (2) leads to overestimating R0, the
bias being at its maximum when the variance s2G is set to 0, while overestimating the variability
of G (as we do if we consider the distribution of S as a proxy of the distribution of G) leads to
underestimating R0.
It is thus important to get a correct estimate of s2G. To achieve this from an estimate of s
2
S ,
we consider that G and S are related as follows:
S ¼ Gþ ðI2   I1Þ: ð3Þ
In (3), I1 and I2 refer to the incubation period, i.e., the time between the infection and the
onset of symptoms in a diseased subject for the infector and for the infected, respectively. If we
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I , combining according to (4) an
estimate ŝ2S of the serial interval variance found in a study of infector-infected pairs, with an
estimate ŝ2I of the incubation period variance obtained in a study of diseased subjects for
whom the dates of infection (and the symptoms onsets dates) are available. An estimate m̂ of
the mean of S (corresponding to the mean of G) was also taken from the literature on infector-





expð  r̂tÞgðt; m̂; ŝ2GÞdt
: ð5Þ
In (5), we assumed either a Weibull or a gamma distribution for G. With a gamma distribu-
tion, we could use the explicit form (2), whereas a numerical integration was used in the case
of the Weibull distribution, for which the moment generating function has no explicit form.
Confidence intervals for R0 were obtained based on 10’000 simulations from the sampling
distributions of the estimates [24, 25], as detailed in the S1 Appendix. Our code was written
using the R statistical software [26] and is available upon request.
Results
Fig 1 shows the cumulative incidences of COVID-19 (and thus all the data used in this analy-
sis) on the logarithmic scale over the selected period for the 15 countries. As already men-
tioned, the data were remarkably aligned (as they should be at the start of an exponentially
growing outbreak), with slopes that were similar for most countries. Our estimation of the
exponential growth rates ρ ranged from log(1.25) for Germany to log(1.42) and log(1.43) for
Spain and Portugal, the weighted average over the 15 countries being r̂ = log(1.32) (95% CI:
log(1.29)-log(1.35)).
Reliable estimates of the mean and variance of the serial interval S can be found in Du et al.
[18] based on a large number of infector-infected pairs (n = 468). Using a normality assump-
tion for S, they estimated a mean m̂ ¼ 3:96 ð95% CI : 3:53   4:39Þ and a variance of
ŝ2S ¼ 4:75
2 ð95% CI : 4:462   5:072Þ. Concerning the variance of the incubation period I, we
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used the estimate ŝ2I ¼ 2:3
2 ð95% CI : 1:72   3:72Þ obtained by Backer et al. [27] based on
n = 88 diseased subjects for whom the dates of infection could be retrieved, assuming a Wei-
bull distribution (which yielded a better fit than that of a gamma distribution). Putting these
results together as explained in the Methods section and by assuming a Weibull distribution
for G, we obtained an estimate of its variance of ŝ2G ¼ 3:46
2 ð95% CI : 2:412   4:952Þ, and
finally of the basic reproductive number for COVID-19 in Western Europe, which is given by
R̂0 ¼ 2:21 ð95% CI : 1:86   2:63Þ:
Table 1 provides some alternative estimates of R0 by assuming gamma instead of Weibull
distributions for I and/or G. While considering a gamma (instead of a Weibull) distribution
for G had almost no influence, our estimate of R0 increased slightly (from 2.2 to 2.3) when we
considered a gamma (instead of a Weibull) distribution for I. This was due to a slight increase
of estimate ŝI ¼ 2:6 ð95% CI : 1:8   4:2Þ found in Backer et al. [27] in the case of a gamma
distribution, leading in turn to a decrease of estimate ŝG ¼ 3:01 ð95% CI : 1:57   5:71Þ.
Discussion
The value of R0 for an infectious disease, such as COVID-19, depends not only on the biologi-
cal characteristics of the disease but also on the social habits of the population and might thus
be different from country to country. In this paper, we provide an estimation of R0 for
COVID-19 in Western Europe. To achieve this, we have combined the cumulative incidences
of COVID-19 reported at the start of the outbreak in the 15 largest countries in Western
Europe, with an estimation of the parameters of the generation interval distribution recon-
structed from the literature.
In contrast with other authors [18, 22] who used the parameters of the serial interval distri-
bution as a proxy for those of the generation interval distribution, we have reconstructed the
latter from estimates of the former, also integrating an estimate of the variance of the incuba-
tion period in a similar spirit as Ganyani et al. [19]. As these authors do, and as is also common
in applications in chemistry or physics [28], we have combined estimates from different (and
independent) data sources, looking for the best possible (most reliable) estimate for each bio-
logical parameter. In particular, the reliable estimates of these quantities, i.e., estimates based
on large data sets, that we were able to find in the literature used Chinese, and not European
data, which is a limitation of our study. However, the incubation period is mainly a biological
characteristic, which should be similar in most countries of the world. The generation interval
(and thus the serial interval) also depends (among other characteristics) on the viral load,
another biological characteristic, so we hope that the estimates obtained in China also largely
apply in Europe. Nevertheless, researchers can still update our calculations using estimates of
the mean and variance of the serial interval based on European data (once available). On the
Table 1.
I G R̂^0
Weibull Weibull 2.21 (95% CI : 1.86–2.63)
Weibull Gamma 2.22 (95% CI: 1.84–2.64)
Gamma Weibull 2.32 (95% CI: 1.77–2.89)
Gamma Gamma 2.34 (95% CI: 1.73–2.91)
Summary of the estimates R̂^0 of the basic reproductive number using various assumptions for the distributions of the
incubation period I and generation interval G.
https://doi.org/10.1371/journal.pone.0248731.t001
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other hand, we found that the shape of the distribution (e.g., Weibull or gamma) of the genera-
tion interval had only a minimal impact on our final estimates.
As mentioned in the Introduction, most studies about R0 for COVID-19 were done for
(various regions of) China [22], for which a meta-analysis reported an estimate of 3.3 for R0
[6]. Our estimate of 2.2 is thus significantly lower than that in China. This might be due to a
higher number of daily contacts for a citizen in China than for a citizen in Europe because of
the dense populations in Chinese cities. This might also be due to methodological issues, since,
as mentioned in our Methods section, ignoring the variance of the generational interval leads
to an overestimation of R0. In contrast, in one of the rare studies performed in Europe, R0 was
estimated to be approximately 3.3, 6.3, 6.1 and 5.1 in Italy, France, Germany and Spain, respec-
tively [9]. However, the authors used the incubation period as a proxy for the generational
interval. This is quite questionable, particularly since the incubation period for COVID-19 typ-
ically has a larger mean than the generation (as well as the serial) interval (e.g., 6 days instead
of 4 days).
In an impressive study combining epidemiological data from China with synthetic contact
matrices to capture country-specific contact behavior, Hilton and Keeling [12] estimated an R0
in 152 countries, including 14 out of the 15 European countries considered here (Norway was
not included). An average of their estimates of R0 over these 14 countries would be 2.1 if we
consider their simpler model, and 3.0 if we consider their more complex model, their estimates
being highly dependent of the complexity of the mathematical model used, as recognized by
the authors. In contrast, our estimate was obtained in a relatively simple and totally transpar-
ent manner.
We are not claiming that the value of R0 is the same in each European country. However,
despite some legitimate doubt about the quality and reliability of some official statistics on the
incidence of COVID-19 in some countries and despite the different testing strategies that were
applied in different European countries, the spread of the disease appears to be remarkably
similar in almost all countries, as shown in Fig 1. In such a homogeneous context, calculating
an “average R0” to summarize the spread of the disease in Western Europe appears relevant to
us, justifying the application of the principle of “borrowing strength” mentioned in the
Introduction.
In summary, the value of R0 for COVID-19 in Western Europe might be slightly lower than
the values that are sometimes reported in other countries (e.g., on Wikipedia, where the
reported values of R0 are up to 6). A practical consequence of this is that the proportion of
immune persons in the European population required to stop the outbreak is estimated to be
1-1/2.2 = 55%, which is closer to 50% than to 70%. This might be a useful message at a time
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Writing – original draft: Isabella Locatelli, Bastien Trächsel, Valentin Rousson.
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